Recombinant human hyaluronidase (rHuPH20): an enabling platform for subcutaneous drug and fluid administration

This publication has 54 references indexed in Scilit:

• Replacement IgG therapy and self-therapy at home improve the health-related quality of life in patients with primary antibody deficiencies
  Current Opinion in Allergy and Clinical Immunology, 2006
• Endocytic Function, Glycosaminoglycan Specificity, and Antibody Sensitivity of the Recombinant Human 190-kDa Hyaluronan Receptor for Endocytosis (HARE)
  Published by Elsevier ,2004
• Purification, Cloning, and Expression of Human Plasma Hyaluronidase
  Biochemical and Biophysical Research Communications, 1997
• Hyaluronidase as an antidote to extravasation ofVinca alkaloids: Clinical results
  Zeitschrift für Krebsforschung und Klinische Onkologie, 1994
• The human sperm protein PH‐20 has hyaluronidase activity
  FEBS Letters, 1993
• cDNA cloning reveals the molecular structure of a sperm surface protein, PH-20, involved in sperm-egg adhesion and the wide distribution of its gene among mammals.
  The Journal of cell biology, 1990
• Analysis of the Products Formed on Hydrolysis of Hyaluronic Acid by Testicular Hyaluronidase^1,2
  Journal of the American Chemical Society, 1951
• The clinical use of hyaluronidase in hypodermoclysis
  The Journal of Pediatrics, 1947
• CHEMICAL PROPERTIES OF THE PURIFIED SPREADING FACTOR FROM TESTICLE
  The Journal of Experimental Medicine, 1937
• FURTHER STUDIES ON THE INFLUENCE OF TESTICLE EXTRACT UPON THE EFFECT OF TOXINS, BACTERIA, AND VIRUSES, AND ON THE SHWARTZMAN AND ARTHUS PHENOMENA
  The Journal of Experimental Medicine, 1933